| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 3,569.40 | 3,274.95 | 3,193.05 | 3,318.77 |
| Accumulated Depreciation Total | -685.93 | -585.96 | -476.46 | -378.86 |
| Cash Equivalents | 0.79 | - | - | - |
| Other Liabilities Total | 40.84 | 36.67 | 43.00 | 44.65 |
| Accrued Expenses | 17.90 | 22.58 | 34.00 | 18.32 |
| Long Term Debt | 60.81 | 38.22 | 63.65 | 89.01 |
| Common Stock Total | 14.08 | 14.08 | 14.08 | 14.08 |
| Other Equity Total | -14.73 | -7.76 | -2.12 | 73.78 |
| Other Current Assets Total | 0.94 | 1.29 | 2.19 | 1.59 |
| Prepaid Expenses | 22.12 | 21.13 | 23.43 | 21.05 |
| Total Assets | 3,569.40 | 3,274.95 | 3,193.05 | 3,318.77 |
| Current Portof LT Debt/ Capital Leases | 33.48 | 29.87 | 30.82 | 29.88 |
| Additional Paid- In Capital | 1.33 | 1.33 | 1.33 | 1.33 |
| Cash | 26.41 | 28.02 | 33.72 | 25.37 |
| Total Equity | 2,450.59 | 2,438.30 | 2,435.30 | 2,618.41 |
| Long Term Investments | 8.29 | 5.93 | 0.16 | 3.28 |
| Retained Earnings( Accumulated Deficit) | 2,435.21 | 2,386.45 | 2,422.01 | 2,529.22 |
| Total Common Shares Outstanding | 7.04 | 7.04 | 7.04 | 7.04 |
| Property/ Plant/ Equipment Total- Gross | 1,995.92 | 1,903.16 | 1,879.03 | 1,861.16 |
| Tangible Book Valueper Share Common Eq | 345.19 | 338.10 | 345.68 | 371.68 |
| Goodwill Net | 1.55 | 1.55 | 1.55 | 1.55 |
| Total Liabilities | 1,118.81 | 836.65 | 757.74 | 700.36 |
| Total Debt | 459.77 | 247.52 | 314.05 | 349.15 |
| Short Term Investments | 89.49 | 130.19 | 151.68 | 350.72 |
| Cashand Short Term Investments | 116.69 | 158.21 | 185.40 | 376.09 |
| Total Receivables Net | 896.49 | 818.41 | 748.68 | 645.97 |
| Notes Payable/ Short Term Debt | 340.29 | 155.27 | 208.08 | 215.69 |
| Deferred Income Tax | 0.00 | 0.00 | - | 0.00 |
| Accounts Receivable- Trade Net | 780.20 | 642.54 | 588.75 | 495.98 |
| Property/ Plant/ Equipment Total- Net | 1,309.99 | 1,317.20 | 1,402.57 | 1,482.30 |
| Total Current Liabilities | 991.97 | 737.60 | 639.60 | 552.13 |
| Total Inventory | 993.23 | 744.28 | 628.76 | 600.22 |
| Accounts Payable | 402.55 | 351.26 | 290.69 | 183.19 |
| Other Currentliabilities Total | 197.75 | 178.62 | 76.01 | 105.05 |
| Total Long Term Debt | 86.00 | 62.38 | 75.14 | 103.58 |
| Intangibles Net | 18.70 | 56.36 | 0.00 | 0.00 |
| Other Long Term Assets Total | 65.81 | 38.05 | 44.87 | 30.35 |
| Note Receivable- Long Term | 135.59 | 112.54 | 155.43 | 156.36 |
| Unrealized Gain( Loss) | 14.70 | 44.20 | - | - |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 2,029.47 | 1,743.32 | 1,588.47 | 1,644.92 |
| Capital Lease Obligations | 25.19 | 24.16 | 11.49 | 14.57 |
Unichem Laboratories Dividend Unichem Laboratories Bonus Unichem Laboratories News Unichem Laboratories AGM Unichem Laboratories Rights Unichem Laboratories Splits Unichem Laboratories Board Meetings Unichem Laboratories Key Metrics Unichem Laboratories Shareholdings Unichem Laboratories Profit Loss Unichem Laboratories Cashflow Unichem Laboratories Q1 Results Unichem Laboratories Q2 Results Unichem Laboratories Q3 Results Unichem Laboratories Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks